Altro Health (formerly Lyv Health) provides clinical software and services to solo-preneurs and SMBs in the health, wellness, and fitness sectors who want to offer additional medical-grade services to their clients related to peptides, including GLP-1s. The company operates like a “clinical Shopify for wellness,” enabling health coaches, medspas, and gyms to offer services like blood testing, and prescriptions. The company was founded in 2025, is based in NYC, and is backed by NFX and other top healthcare angels. 

Here’s why we invested: 

1. Fastest Growing Sector in Consumer Healthcare

Consumer demand for peptides – from GLP-1s to peptides affecting recovery, inflammation, and immune support –  is perhaps the biggest development in healthcare in a decade. The market is projected to surpass $160B in 2026, and continue that upward trend. Regulatory change is also likely to enable faster growth in this sector: A recent US Health and Human Services policy shift allows 14 popular peptides to return to legal compounding status. 

Many entrepreneurs are building DTC brands around the peptide market. But no one has approached this market from the platform perspective – serving the SMBs who act as the market’s consumer-facing front lines. Altro’s platform enables SMBs to expand access to medical-grade services that would otherwise prove too complex or expensive. 

2. The Team 

The two co-founders met at Harvard Business School and have been working on this ever since. They’re particularly well suited to win this market. 

CEO Andrea Corleto has a powerful “why” for building Altro, built around her personal connection to the wellness market. She has a chronic medical condition with no cure, so she has spent much of her life searching for wellness therapies to increase her healthspan. She also has instincts for rapid growth necessary in this changing market – she was the head of growth at a consumer product company for six years, growing it to a $1B valuation. 

COO Jennifer Arnold has been in the health and wellness industry for over ten years and has successfully secured FDA approvals. 

Importantly, the team also has key medical advisors from Johns Hopkins, The Mayo Clinic, and Harvard Medical School, providing deep expertise and understanding of this space. 

3. Network Effects

Altro Health is building a defensible platform with clear network effects. 

The network of wellness service providers that use its platform serves as the supply side of a marketplace. Those providers can offer a wide range of services, content, and treatments to SMBs on the demand side. Once embedded with those providers, Altro can negotiate better pricing and service from backend providers and expand both offerings and margins.

This approach allows Altro to grow far larger and faster than building a DTC brand would – a path that lacks defensibility and is subject to race-to-the-bottom dynamics. This approach is self-sustaining, with the potential to become enduring over time. 

Learn more about Altro Health here.